Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07159503

VISOR Versus PCNL for Treatment of 2-4cm Renal Stones

Vortex Intelligence Stone Optimized Removal Versus Percutaneous Nephrolithotomy for Treatment of 2-4cm Renal Stones

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if the Vortex Intelligence Stone Optimized Removal (VISOR) works safely and effectively to treat kidney stones that are 2 to 4 centimeters in size in kidney. This study will also look at how VISOR compares to the standard surgery, percutaneous nephrolithotomy (PCNL). The main questions it aims to answer are: How many participants are stone-free within 24 hours after surgery? How many participants are stone-free 1 month after surgery? What side effects or problems, such as pain, fever, or ureter injury, happen with VISOR compared to PCNL? Does VISOR help keep kidney pressure stable during surgery? Researchers will compare VISOR to PCNL to see which treatment works better and is safer. Participants will: Be randomly assigned to have surgery with either VISOR or PCNL. Have imaging tests, such as CT scans or ultrasound, after surgery to check if stones were cleared. Return for follow-up visits about 2 weeks and 1 month after surgery to check recovery and repeat imaging. About 170 people will take part in this study at cooperative hospitals.

Conditions

Interventions

TypeNameDescription
PROCEDUREVortex Intelligence Stone Optimized RemovalVortex Intelligence Stone Optimized Removal integrates irrigation-suction, pressure monitoring-control, and lithotripsy-stone removal functions, aiming to improve stone clearance efficiency, stabilize intrapelvic pressure, and reduce complications.
PROCEDUREPercutaneous Nephrolithotomy (PCNL)A standard PCNL technique will be performed according to institutional practice guidelines.

Timeline

Start date
2025-04-20
Primary completion
2027-02-20
Completion
2027-08-20
First posted
2025-09-08
Last updated
2025-09-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07159503. Inclusion in this directory is not an endorsement.